The Executive Committee (EC) is composed of the SCOR Director and Co-Directors (Drs. Brady, See, and McRae-Clark). This committee meets monthly to review operations, progress and problem areas and on an as-needed basis for emergent issues affecting the SCOR. This committee provides internal checks and balances and affords individual PI’s an opportunity to discuss/appeal administrative and fiscal decisions.

Kathleen T. Brady, M.D., Ph.D.
SCOR Director  
Dr. Brady has served as the Director and PI of the MUSC SCOR for the past nine years.  She is a Distinguished University Professor, psychiatrist and pharmacologist with a lengthy record of federally-funded clinical and translational research and considerable experience in teaching and research mentoring.  She has achieved national and international prominence for her research in the area of psychiatric comorbidity and addictions, and has over 300 scientific publications in this area.  Dr. Brady is also the PI for the NIH-sponsored Clinical Trials Network (CTN), which was initially funded in 2000 and funded again through competitive renewals in 2005 and 2010.  Dr. Brady serves as the Program Director of the MUSC General Clinical Research Center (GCRC) and Associate Dean for Clinical Research in the College of Medicine at MUSC.  In 2009, she led a successful application for a CTSA to form the South Carolina Clinical and Translational Research Institute (SCTR), which she now directs.  This position has enhanced her administrative experience, widened her research perspective and places her in an ideal position to continue to improve the visibility and prioritization of research in women’s health on the MUSC campus.

Ronald E. See, Ph.D.
SCOR Co-Director, Basic Science & Pilot Project Program

Dr. See has been a full Professor in the MUSC Departments of Neurosciences and Psychiatry since 1999.  He played a pivotal leadership role in the establishment of the Neurosciences program and several addiction research initiatives at MUSC.  Dr. See has published more than 140 scientific papers and reviews, has made numerous national and international scientific presentations, served in a variety of capacities in national committees and organizations, and has been continuously funded by NIH since 1991.  In addition to his extensive work in animal models of addiction and relapse, he has developed a strong focus on translational research, including experience in clinical settings.  He previously directed a schizophrenia treatment study and served as a co-investigator in several recent clinical cue and stress reactivity studies.  Some of the current research in his laboratory is focused towards preclinical testing of pharmacotherapies for drug dependence, including compounds being assessed by Dr. Brady and colleagues.  Working closely with Dr. Brady, Dr. See has developed his studies using animal models of relapse in parallel with the human clinical laboratory to study cue, stress, and drug reactivity following chronic self-administration of drugs of abuse.  Dr. See is also a Core Director in the Neurobiology of Addiction Research Center at MUSC and a co-investigator in the MUSC Alcohol Research Center.  He has an extensive record of mentoring trainees in research activities, and over the last 25 years, he has served as a mentor for a number of undergraduate and pre-doctoral students, postdoctoral fellows, and junior faculty.

Aimee McRae-Clark, Pharm.D., BCPP
SCOR Co-Director, Clinical Science Projects/Outreach Program

Dr. McRae-Clark has been a member of the SCOR investigative team since its inception, and assisted in directing the Administrative Core during the last funding period. .She served as a Co-I on a component of the initial SCOR application (Gender differences in response to cues in cocaine dependence, PI: Brady), and is currently participating as a component Co-PI in the current center (Stress-induced craving: The impact of gender and ovarian hormones).  She has served as PI or Co-I on more than twenty clinical trials, and as such has a wealth of experience conducting clinical research. She has mentored a number of graduate students, post-doctoral fellows, and junior faculty and is a member of the BIRCWH Steering Committee. She has a history of successful collaborations with both Drs. Brady and See developing human clinical laboratory paradigms to run in parallel with preclinical models. She is also active in several outreach programs that will help facilitate the MUSC SCOR’s proposed community engagement efforts, and her appointments in multiple colleges and departments across MUSC will help in cross-campus collaborations.

Harriet de Wit, Ph.D.
Professor
Department of Psychiatry and Behavioral Neuroscience
The University of Chicago

Etta D. Pisano, M.D.
Vice President for Medical Affairs
Dean, College of Medicine
Medical University of South Carolina

Peter Kalivas, Ph.D.
Distinguished University Professor
Professor and Co-Chair, Department of Neurosciences
Professor, Department of Psychiatry and Behavioral Sciences
Medical University of South Carolina